School of Pharmacy, University of Eastern Finland, Yliopistonranta 1B, 70210, Kuopio, Finland.
Faculty of Medicine and Life Sciences, University of Tampere and Tampere University Hospital, 33520, Tampere, Finland; Department of Surgery, Seinäjoki Central Hospital, Seinäjoki, Finland; Tampere University Hospital, Department of Urology, Tampere, Finland.
J Pharm Biomed Anal. 2019 Feb 5;164:642-652. doi: 10.1016/j.jpba.2018.11.035. Epub 2018 Nov 16.
This study describes a validated LC-MS/MS method for assaying 23 steroids within a single run from 150 μl of human plasma, serum or prostatic tissue homogenate. Isotope-labeled steroids were used as internal standards. Samples were extracted with toluene, and ketosteroids were derivatized with hydroxylamine prior to LC-MS/MS analysis. The steroids were separated on a C18 column and methanol was used as an organic solvent with the addition of 0.2 mM ammonium fluoride to improve underivatized estradiol (E2) ionization. Certified reference serums as well as plasma samples, and homogenates of prostate tissue were utilized in the method validation. The specificity of the method was inspected with a total of 27 steroids. The validation proved that the method was suitable for the quantitative analysis of a wide panel of androgens (testosterone, T (3.3 pM-13 nM); androstenedione, A4 (3.3 pM-13 nM); 5α-androstanedione, DHA4 (13 pM-13 nM); dehydroepiandrosterone, DHEA (67 pM-133 nM); dihydrotestosterone, DHT (33 pM-33 nM); 11-ketodihydrotestosterone, 11KDHT (13 pM-13nM); 11-ketotestosterone, 11KT (33 pM-6.7 nM); 11β-hydroxyandrostenedione, 11bOHA4 (33 pM-13 nM); 11β-hydroxytestosterone, 11OHT (13 pM-33 nM)), as well as estrogens (estrone, E1 (3.3 pM-13 nM)), progestagens (17α-hydroxypregnenolone, 17OHP5 (32 pM-127 nM); 17α-hydroxyprogesterone, 17OHP4 (67 pM-133 nM); progesterone, P4 (3.3 pM-13 nM); pregnenolone, P5 (6.6 pM-13 nM)), and glucocorticoids (cortisol, F (33 pM-134 nM); cortisone E (66 pM-131 nM); corticosterone, B (33 pM-67 nM); 11-deoxycortisol, S (33 pM-66 nM); 21-hydroxyprogesterone, 21OHP4 (32 pM-13 nM)). Furthermore, E2 (335 pM-134 nM) and 11α-hydroxyandrostenedione, 11aOHA4 (33 pM-33 nM) could be analyzed if the concentration in the sample was high enough. In addition, aldosterone, A (128 pM-64 nM) and 11-ketoandrostenedione, 11KA4 (33 pM-13 nM) could be analyzed semiquantitatively. The limits of quantification for all compounds ranged from 0.9 to 91 pg/ml, and from 0.009 to 0.9 pg/mg tissue. Compared to our previous method, this new method also permits the analysis of the more challenging steroids, like DHT, DHEA and P5, and a panel of 11-ketosteroids.
本研究描述了一种从 150μl 人血浆、血清或前列腺组织匀浆中同时测定 23 种类固醇的经验证的 LC-MS/MS 方法。使用同位素标记的类固醇作为内标。样品用甲苯提取,酮类固醇用羟胺衍生化,然后进行 LC-MS/MS 分析。类固醇在 C18 柱上分离,甲醇中添加 0.2mM 氟甲酰胺以改善未衍生化雌二醇(E2)的离子化。使用认证参考血清以及血浆样品和前列腺组织匀浆进行方法验证。该方法的特异性用总共 27 种类固醇进行了检查。验证证明该方法适用于广泛的雄激素(睾酮、T(3.3pM-13nM);雄烯二酮、A4(3.3pM-13nM);5α-雄烷二酮、DHA4(13pM-13nM);脱氢表雄酮、DHEA(67pM-133nM);二氢睾酮、DHT(33pM-33nM);11-酮二氢睾酮、11KDHT(13pM-13nM);11-酮睾酮、11KT(33pM-6.7nM);11β-羟基雄烯二酮、11bOHA4(33pM-13nM);11β-羟睾酮、11OHT(13pM-33nM))以及雌激素(雌酮、E1(3.3pM-13nM))、孕激素(17α-羟孕烯醇酮、17OHP5(32pM-127nM);17α-羟孕酮、17OHP4(67pM-133nM);孕酮、P4(3.3pM-13nM);孕烯醇酮、P5(6.6pM-13nM))和糖皮质激素(皮质醇、F(33pM-134nM);皮质酮 E(66pM-131nM);皮质醇、B(33pM-67nM);11-脱氧皮质醇、S(33pM-66nM);21-羟孕酮、21OHP4(32pM-13nM))的定量分析。此外,如果样品中的浓度足够高,还可以分析雌二醇(E2(335pM-134nM))和 11α-羟基雄烯二酮、11aOHA4(33pM-33nM)。此外,醛固酮、A(128pM-64nM)和 11-酮雄烯二酮、11KA4(33pM-13nM)也可以进行半定量分析。所有化合物的定量限范围为 0.9 至 91pg/ml,0.009 至 0.9pg/mg 组织。与我们之前的方法相比,这种新方法还允许分析更具挑战性的类固醇,如 DHT、DHEA 和 P5,以及一组 11-酮类固醇。